Am J Psychiatry 1992; 149:443-454
Copyright © 1992 by American Psychiatric Association

SPECIAL ARTICLES

Depression and Parkinson's disease: a review

JL Cummings
Department of Neurology, University of California, School of Medicine, Los Angeles.

OBJECTIVE: The purpose of this review is to provide an update of the research regarding depression in Parkinson's disease and to synthesize the information into a neurobiological model relating the structural and biochemical changes in this disorder to the behavioral manifestations. METHOD: The author used a computer-based search of the literature, augmented by extensive bibliography-guided article reviews, to find information on depression and Parkinson's disease. FINDINGS: Depression occurs in approximately 40% of patients with Parkinson's disease; depression in Parkinson's disease is distinguished from other depressive disorders by greater anxiety and less self-punitive ideation. Lower CSF levels of 5-hydroxyindoleacetic acid, a past history of depression, and greater functional disability are associated with a greater risk of depression in Parkinson's disease. Female gender, early age at onset of Parkinson's disease, and greater left brain involvement may also be risk factors. Approximately half of depressed patients with Parkinson's disease meet criteria for major depressive episodes; half have dysthymia. Depression is more common in Parkinson's disease with prominent bradykinesia and gait instability than in tremor-dominant syndromes. Depressed patients with Parkinson's disease have greater frontal lobe dysfunction and greater involvement of dopaminergic and noradrenergic systems than nondepressed patients with the disease. Mood changes in Parkinson's disease respond to treatment with conventional tricyclic antidepressants or ECT. CONCLUSIONS: Neurobiological investigations suggest that depression in Parkinson's disease may be mediated by dysfunction in mesocortical/prefrontal reward, motivational, and stress-response systems. Neuropsychological, metabolic, clinical, pharmacological, and anatomical studies support the involvement of frontal dopaminergic projections in patients with Parkinson's disease and depression.

This article has been cited by other articles:

				J. J. Chen, D. P. Trombetta, and H. H. Fernandez Palliative Management of Parkinson Disease: Focus on Nonmotor, Distressing Symptoms Journal of Pharmacy Practice, August 1, 2008; 21(4): 262 - 272. [Abstract] [PDF]

				K. Oehlberg, F. K. Barg, G. K. Brown, D. Taraborelli, M. B. Stern, and D. Weintraub Attitudes Regarding the Etiology and Treatment of Depression in Parkinson's Disease: A Qualitative Study J Geriatr Psychiatry Neurol, June 1, 2008; 21(2): 123 - 132. [Abstract] [PDF]

				H. B. Lee, W. A. Hening, R. P. Allen, A. E. Kalaydjian, C. J. Earley, W. W. Eaton, and C. G. Lyketsos Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 101 - 105. [Abstract] [Full Text] [PDF]

				G. Arabia, B. R. Grossardt, Y. E. Geda, J. M. Carlin, J. H. Bower, J. E. Ahlskog, D. M. Maraganore, and W. A. Rocca Increased Risk of Depressive and Anxiety Disorders in Relatives of Patients With Parkinson Disease Arch Gen Psychiatry, December 1, 2007; 64(12): 1385 - 1392. [Abstract] [Full Text] [PDF]

				Peijun Chen, H. C. Kales, D. Weintraub, F. C. Blow, Lan Jiang, and A. M. Mellow Antidepressant Treatment of Veterans With Parkinson's Disease and Depression: Analysis of a National Sample J Geriatr Psychiatry Neurol, September 1, 2007; 20(3): 161 - 165. [Abstract] [PDF]

				U. Walter, J. Hoeppner, L. Prudente-Morrissey, S. Horowski, S. C. Herpertz, and R. Benecke Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders Brain, July 1, 2007; 130(7): 1799 - 1807. [Abstract] [Full Text] [PDF]

				D. Bowers, K. Miller, A. Mikos, L. Kirsch-Darrow, U. Springer, H. Fernandez, K. Foote, and M. Okun Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli Brain, December 1, 2006; 129(12): 3356 - 3365. [Abstract] [Full Text] [PDF]

				O. L. Lopez, J. T. Becker, R. A. Sweet, F. J. Martin-Sanchez, and R. L. Hamilton Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology, August 22, 2006; 67(4): 660 - 665. [Abstract] [Full Text] [PDF]

				F. Fregni, C. R. Ono, C. M. Santos, F. Bermpohl, C. Buchpiguel, E. R. Barbosa, M. A. Marcolin, A. Pascual-Leone, and K. D. Valente Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD Neurology, June 13, 2006; 66(11): 1629 - 1637. [Abstract] [Full Text] [PDF]

				R. DeFronzo Dobkin, L. A. Allen, and M. Menza A Cognitive-Behavioral Treatment Package for Depression in Parkinson's Disease Psychosomatics, June 1, 2006; 47(3): 259 - 263. [Full Text] [PDF]

				M Brandt-Christensen, K Kvist, F M Nilsson, P K Andersen, and L V Kessing Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J. Neurol. Neurosurg. Psychiatry, June 1, 2006; 77(6): 781 - 783. [Abstract] [Full Text] [PDF]

				M. Samuel, I. Maidment, M. Boustani, and C. Fox Clinical management of Parkinson's disease dementia: pitfalls and progress Advan. Psychiatr. Treat., March 1, 2006; 12(2): 121 - 129. [Abstract] [Full Text] [PDF]

				F S Ertan, T Ertan, G Kiziltan, and H Uygucgil Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1445 - 1447. [Abstract] [Full Text] [PDF]

				C. Veazey, S. Ozlem Erden Aki, K. F. Cook, E. C. Lai, and M. E. Kunik Prevalence and Treatment of Depression in Parkinson's Disease J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 310 - 323. [Abstract] [Full Text] [PDF]

				R. RUDDY and A. HOUSE Meta-review of high-quality systematic reviews of interventions in key areas of liaison psychiatry The British Journal of Psychiatry, August 1, 2005; 187(2): 109 - 120. [Abstract] [Full Text] [PDF]

				M. R. Lemke, H. M. Brecht, J. Koester, P. H. Kraus, and H. Reichmann Anhedonia, Depression, and Motor Functioning in Parkinson's Disease During Treatment With Pramipexole J Neuropsychiatry Clin Neurosci, May 1, 2005; 17(2): 214 - 220. [Abstract] [Full Text] [PDF]

				H Sienkiewicz-Jarosz, A Scinska, W Kuran, D Ryglewicz, A Rogowski, E Wrobel, A Korkosz, A Kukwa, W Kostowski, and P Bienkowski Taste responses in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 40 - 46. [Abstract] [Full Text] [PDF]

				N. Turjanski and G. G. Lloyd Psychiatric side-effects of medications: recent developments Advan. Psychiatr. Treat., January 1, 2005; 11(1): 58 - 70. [Abstract] [Full Text] [PDF]

				A. F. G. Leentjens Depression in Parkinson's Disease: Conceptual Issues and Clinical Challenges J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 120 - 126. [Abstract] [PDF]

				M. Menza, H. Marin, K. Kaufman, M. Mark, and M. Lauritano Citalopram Treatment of Depression in Parkinson's Disease: The Impact on Anxiety, Disability, and Cognition J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 315 - 319. [Abstract] [Full Text] [PDF]

				R. Vataja, A. Leppavuori, T. Pohjasvaara, R. Mantyla, H. J. Aronen, O. Salonen, M. Kaste, and T. Erkinjuntti Poststroke Depression and Lesion Location Revisited J Neuropsychiatry Clin Neurosci, May 1, 2004; 16(2): 156 - 162. [Abstract] [Full Text] [PDF]

				D. J. Brunswick, J. D. Amsterdam, P. D. Mozley, and A. Newberg Greater Availability of Brain Dopamine Transporters in Major Depression Shown by [99mTc]TRODAT-1 SPECT Imaging Am J Psychiatry, October 1, 2003; 160(10): 1836 - 1841. [Abstract] [Full Text] [PDF]

				B R Thanvi, S K Munshi, N Vijaykumar, and T C N Lo Neuropsychiatric non-motor aspects of Parkinson's disease Postgrad. Med. J., October 1, 2003; 79(936): 561 - 565. [Abstract] [Full Text] [PDF]

				J.-M. Itier, P. Ibanez, M. A. Mena, N. Abbas, C. Cohen-Salmon, G. A. Bohme, M. Laville, J. Pratt, O. Corti, L. Pradier, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Hum. Mol. Genet., September 15, 2003; 12(18): 2277 - 2291. [Abstract] [Full Text] [PDF]

				C. E. Garber and J. H. Friedman Effects of fatigue on physical activity and function in patients with Parkinson's disease Neurology, April 8, 2003; 60(7): 1119 - 1124. [Abstract] [Full Text] [PDF]

				A.F.G. Leentjens, J. Marinus, J.J. Van Hilten, R. Lousberg, and F.R.J. Verhey The Contribution of Somatic Symptoms to the Diagnosis of Depressive Disorder in Parkinson's Disease: A Discriminant Analytic Approach J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 74 - 77. [Abstract] [Full Text] [PDF]

				B. A. Racette, J. M. Hartlein, T. Hershey, J. W. Mink, J. S. Perlmutter, and K. J. Black Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease J Neuropsychiatry Clin Neurosci, November 1, 2002; 14(4): 438 - 442. [Abstract] [Full Text] [PDF]

				P. Naarding, A. F. G. Leentjens, F. van Kooten, and F. R.J. Verhey Disease-Specific Properties of the Hamilton Rating Scale for Depression in Patients With Stroke, Alzheimer's Dementia, and Parkinson's Disease J Neuropsychiatry Clin Neurosci, August 1, 2002; 14(3): 329 - 334. [Abstract] [Full Text] [PDF]

				K. Wheatley, R. L Stowe, C. E Clarke, R. K Hills, A. C Williams, and R. Gray Evaluating drug treatments for Parkinson's disease: how good are the trials? BMJ, June 22, 2002; 324(7352): 1508 - 1511. [Full Text] [PDF]

				J L Houeto, V Mesnage, L Mallet, B Pillon, M Gargiulo, S T. du Moncel, A M Bonnet, B Pidoux, D Dormont, P Cornu, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 701 - 707. [Abstract] [Full Text] [PDF]

				A. G. Schuurman, M. van den Akker, K. T.J.L. Ensinck, J. F.M. Metsemakers, J. A. Knottnerus, A. F.G. Leentjens, and F. Buntinx Increased risk of Parkinson's disease after depression: A retrospective cohort study Neurology, May 28, 2002; 58(10): 1501 - 1504. [Abstract] [Full Text] [PDF]

				M. J. Mentis, A. R. McIntosh, K. Perrine, V. Dhawan, B. Berlin, A. Feigin, C. Edwards, P. Mattis, and D. Eidelberg Relationships Among the Metabolic Patterns That Correlate With Mnemonic, Visuospatial, and Mood Symptoms in Parkinson's Disease Am J Psychiatry, May 1, 2002; 159(5): 746 - 754. [Abstract] [Full Text] [PDF]

				M. S. Turner, L. Mignon, and T. C. Napier Alterations in Responses of Ventral Pallidal Neurons to Excitatory Amino Acids after Long-Term Dopamine Depletion J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 371 - 381. [Abstract] [Full Text] [PDF]

				M. S. Okun and R. L. Watts Depression associated with Parkinson's disease: Clinical features and treatment Neurology, February 1, 2002; 58(90001): S63 - 70. [Abstract] [Full Text]

				H A Ring and J Serra-Mestres Neuropsychiatry of the basal ganglia J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 12 - 21. [Abstract] [Full Text] [PDF]

				V. Kaasinen, E. Nurmi, J. Bergman, O. Eskola, O. Solin, P. Sonninen, and J. O. Rinne Personality traits and brain dopaminergic function in Parkinson's disease PNAS, October 25, 2001; (2001) 231313198. [Abstract] [Full Text] [PDF]

				M. Myslobodsky, F. M. Lalonde, and L. Hicks Are Patients with Parkinson's Disease Suicidal? J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 120 - 124. [Abstract] [PDF]

				V. Kaasinen, E. Nurmi, A. Bruck, O. Eskola, J. Bergman, O. Solin, and J. O. Rinne Increased frontal [18F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex Brain, June 1, 2001; 124(6): 1125 - 1130. [Abstract] [Full Text] [PDF]

				J. R. Slaughter, K. A. Slaughter, D. Nichols, S. E. Holmes, and M. P. Martens Prevalence, Clinical Manifestations, Etiology, and Treatment of Depression in Parkinson's Disease J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 187 - 196. [Abstract] [Full Text] [PDF]

				K. H Karlsen, E. Tandberg, D. Arsland, and J. P Larsen Health related quality of life in Parkinson's disease: a prospective longitudinal study J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 584 - 589. [Abstract] [Full Text] [PDF]

				D. G. C. Owens Commentary Advan. Psychiatr. Treat., September 1, 2000; 6(5): 341 - 343. [Full Text]

				K.-L. Tsang, S.-L. Ho, and S.-K. Lo Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations Neurology, June 27, 2000; 54(12): 2292 - 2298. [Abstract] [Full Text] [PDF]

				D Berg, T Supprian, J Thomae, M Warmuth-Metz, A Horowski, B Zeiler, T Magnus, P Rieckmann, and G Becker Lesion pattern in patients with multiple sclerosis and depression Multiple Sclerosis, June 1, 2000; 6(3): 156 - 162. [Abstract] [PDF]

				K. Mizoguchi, M. Yuzurihara, A. Ishige, H. Sasaki, D.-H. Chui, and T. Tabira Chronic Stress Induces Impairment of Spatial Working Memory Because of Prefrontal Dopaminergic Dysfunction J. Neurosci., February 15, 2000; 20(4): 1568 - 1574. [Abstract] [Full Text] [PDF]

				L. Marsh Neuropsychiatric Aspects of Parkinson's Disease Psychosomatics, February 1, 2000; 41(1): 15 - 23. [Abstract] [Full Text]

				D. Aarsland, J. P Larsen, N. G. Lim, C. Janvin, K. Karlsen, E. Tandberg, and J. L Cummings Range of neuropsychiatric disturbances in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 492 - 496. [Abstract] [Full Text] [PDF]

				M. A. Menza, B. Palermo, R. DiPaola, J. I. Sage, and M. H. Ricketts Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter J Geriatr Psychiatry Neurol, July 1, 1999; 12(2): 49 - 52. [Abstract] [PDF]

				S. C. Yudofsky Parkinson's Disease, Depression, and Electrical Stimulation of the Brain N. Engl. J. Med., May 13, 1999; 340(19): 1500 - 1502. [Full Text]

				D. Aarsland, J. P. Larsen, J. L. Cummings, and K. Laake Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease: A Community-Based Study Arch Neurol, May 1, 1999; 56(5): 595 - 601. [Abstract] [Full Text] [PDF]

				S. J. Mathew, S. C. Yudofsky, L. B. McCullough, T. A. Teasdale, and J. Jankovic Attitudes Toward Neurosurgical Procedures for Parkinson's Disease and Obsessive-Compulsive Disorder J Neuropsychiatry Clin Neurosci, May 1, 1999; 11(2): 259 - 267. [Abstract] [Full Text]

				K. H. Karlsen, J. P Larsen, E. Tandberg, and J. G Mæland Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 431 - 435. [Abstract] [Full Text]

				V Fetoni, P Soliveri, D Monza, D Testa, and F Girotti Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy J. Neurol. Neurosurg. Psychiatry, April 1, 1999; 66(4): 541 - 544. [Abstract] [Full Text]

				I. Litvan, J. L Cummings, and M. Mega Neuropsychiatric features of corticobasal degeneration J. Neurol. Neurosurg. Psychiatry, November 1, 1998; 65(5): 717 - 721. [Abstract] [Full Text]

				W. J.G. Hoogendijk, I.E. C. Sommer, G. Tissingh, D. J.H. Deeg, and E.Ch. Wolters Depression in Parkinson's Disease: The Impact of Symptom Overlap on Prevalence Psychosomatics, October 1, 1998; 39(5): 416 - 421. [Abstract] [Full Text]

				Y. I. Sheline Neuroanatomical Changes Associated with Unipolar Major Depression Neuroscientist, September 1, 1998; 4(5): 331 - 334. [Abstract] [PDF]